$21.28 Billion Neurology Devices Market by 2030: Latest Outlook

The global neurology devices market is projected to reach $21.28 billion by 2030, rising from an estimated $13.90 billion in 2025, at a CAGR of 8.90% during the forecast period. This growth is attributed to the increasing number of neurological disorder cases, the development of innovative brain monitoring and neurostimulation technologies, and the global trend of performing minimally invasive neurosurgical procedures.

Neurology devices are becoming increasingly integral to the detection, treatment, and long-term management of brain, spine, and peripheral nerve disorders as conditions such as Parkinson’s disease, epilepsy, Alzheimer’s disease, stroke, and traumatic brain injury continue to rise, particularly among older adults.

Neurology Devices: The Essentials

Neurology devices encompass diagnostic equipment, monitoring systems, and implantable devices used in the diagnosis and management of diseases of the brain, spinal cord, and peripheral nerves.

Types of neurology devices include:

Diagnostic equipment: Such as EEG and EMG systems for assessing brain and nerve function

Monitoring systems: ICU monitors, ICP monitors, and other devices for real-time tracking of neurological status

Implantable devices: Deep brain stimulators, DBS devices, and vagus nerve stimulators

Device Types Include

✅ Neurostimulation devices (Deep Brain Stimulators, vagus nerve stimulators)

✅ Cerebrospinal fluid (CSF) management devices

✅ Interventional neurology devices (coils, stents, embolization tools)

✅ Neurosurgery devices

✅ Electroencephalography (EEG) and electromyography (EMG) monitoring systems

Factors Driving the Neurology Devices Market Growth

✅ Rising Prevalence of Neurological Disorders

Neurological disorders are the second leading cause of death globally, accounting for 2.1 billion deaths, as per WHO. As the global population ages, neurodegenerative conditions like dementia, Alzheimer’s disease, and stroke are seeing a dramatic increase in prevalence, driving the demand for early diagnostics and therapeutic modalities.

✅ Technological Advances in Neurostimulation

Non-pharmacological neurostimulation techniques like deep brain stimulation (DBS), transcranial magnetic stimulation (TMS), and vagus nerve stimulation (VNS) are seeing increased adoption in managing chronic pain, movement disorders, and depression, opening up new frontiers in neurotherapeutics.

✅ Surge in Minimally Invasive Neurosurgery

Surgeons are increasingly opting for endoscopic neurosurgery, robotic-assisted surgery, 3D imaging-guided procedures, and portable real-time monitoring devices to perform precision surgical interventions with smaller incisions and faster recovery times. This is fueling the need for next-gen neurosurgical devices and intraoperative neuromonitoring systems.

✅ Expansion of Neurodiagnostic Capacity

Hospitals, neuro-specialty clinics, and diagnostic centers are investing in neurodiagnostic equipment to expand their core neurology service capacities and capabilities. EEG, MEG, and MRI/CT-based neuroimaging are witnessing increasing demand for early diagnosis, condition monitoring, and progress assessment.

Market Segmentation

By Product

• Neurostimulation Devices

• Neurosurgery Devices

• Interventional Neurology Devices

• Monitoring and Diagnostic Devices

• CSF Management Systems

By Application

• Parkinson’s Disease

• Alzheimer’s Disease

• Epilepsy

• Stroke

• Multiple Sclerosis

• Migraine

• Chronic Pain

By End User

• Hospitals

• Neurology Clinics

• Ambulatory Surgical Centers (ASCs)

• Research & Academic Institutions

Regional Dominance

North America is the leading market for neurology devices, with the highest adoption of neuro-rehab, surgical robotics, and the most connected network of neurospecialists and academic medical research centers.

Europe is a mature market with a steady growth trajectory, with neurology and neurosurgery-focused specialty centers expanding across Germany, the UK, France, and other European nations.

Asia-Pacific has the highest growth prospects, with improving health access, the rising burden of neurodegenerative conditions, and new government funding for neurotechnology facilities and infrastructure.

Latin America and the Middle East & Africa are emerging markets with diagnostic capability expansion and the growing incidence of neurological diseases.

Major Market Players

Leading companies in the neurology devices market are:

• Medtronic plc

• Abbott Laboratories

• Boston Scientific Corporation

• Stryker Corporation

• Integra LifeSciences

• Natus Medical Inc.

• NeuroPace, Inc.

• LivaNova PLC

Top companies are expanding their R&D investments, developing AI-assisted diagnostic tools, and working on miniaturized neurostimulation and monitoring devices for easy portability, as they seek to grow their presence in new geographies and form partnerships with hospitals, ASCs, and neurology clinics worldwide.

Market Outlook 2030: The Neurotech-Enabled Era

Portable and non-invasive technologies for monitoring brain activity in real time will become ubiquitous, as will personalized neurological care that combines wearables with digital medicine and remote monitoring.

Neurology devices will underpin the delivery of outcome-based, outcome-transparent care focused on improving the patients’ quality of life, with brain health or neurological function serving as the key metrics of disability, wellness, and therapeutic success.

Dive deeper into this market's growth potential.

Get your sample report now at https://www.theresearchinsights.com/request_sample?id=114